Check our new article entitled “Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials” in Rheumatology (Oxford).
Rheumatology key messages
- The protection against renal flares conferred from belimumab is enhanced in the presence of antimalarials.
- Antimalarials protect against renal flares, further supporting its use in all SLE patients unless contraindicated.
- The prominent effect of low-dose belimumab warrants investigation of the efficacy of intermediate belimumab doses.